1.Siglec-15 ablation slowed down tumor growth and prolonged survival.     2. A expansion of tumor-infiltrating CD8+ T and NK cells as well as several inflammatory myeloid populations, whereas a decrease of TAMs and MDSCs. This evidence concerns the gene CD8A and neoplasm.